FSANX
Price
$16.22
Change
-$0.15 (-0.92%)
Updated
Jun 13 closing price
Net Assets
4.3B
RLBBX
Price
$35.35
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

FSANX vs RLBBX

Header iconFSANX vs RLBBX Comparison
Open Charts FSANX vs RLBBXBanner chart's image
Fidelity Asset Manager 60%
Price$16.22
Change-$0.15 (-0.92%)
VolumeN/A
Net Assets4.3B
American Funds American Balanced R2
Price$35.35
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
FSANX vs RLBBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSANX vs. RLBBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSANX is a StrongBuy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 244B vs. FSANX (4.3B). FSANX pays higher dividends than RLBBX: FSANX (2.02) vs RLBBX (1.23). FSANX was incepted earlier than RLBBX: FSANX (18 years) vs RLBBX (23 years). RLBBX (1.32) is less costly to investors than FSANX (0.64). RLBBX is a more actively managed with annual turnover of: 44.00 vs. FSANX (17.00). FSANX has a lower initial minimum investment than RLBBX: FSANX (0) vs RLBBX (250). FSANX annual gain was more profitable for investors over the last year : 7.17 vs. RLBBX (4.47). FSANX return over 5 years is better than : 38.58 vs. RLBBX (34.04).
FSANXRLBBXFSANX / RLBBX
Total Expense Ratio0.641.3248%
Annual Report Gross Expense Ratio0.641.3248%
Fund Existence18 years23 years-
Gain YTD4.7134.082115%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4.3B244B2%
Annual Yield % from dividends2.021.23164%
Returns for 1 year7.174.47160%
Returns for 3 years30.0130.06100%
Returns for 5 years38.5834.04113%
Returns for 10 years58.5451.22114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPBT2.45-0.01
-0.41%
Purple Biotech Ltd
AOS63.81-0.44
-0.68%
AO Smith Corp
VINP9.40-0.12
-1.26%
Vinci Partners Investments Ltd
LEG9.24-0.33
-3.45%
Leggett & Platt
TARA3.14-0.12
-3.68%
Protara Therapeutics